Research advocacy

 

High-level advocacy for diabetes research in Horizon 2020

 

Advocacy with the European institutions was the original motivation to create EURADIA, which emerged from a collaboration of leadership of European diabetes NGOs (academic science, people with diabetes and health professionals) and a number of pharmaceutical companies that approached the Commission in unison to voice their concern that diabetes had not been included in the Sixth Framework Research Programme (FP6). EURADIA has now developed a proactive stance especially within the current discussions over Horizon 2020.

 

EURADIA is following Horizon 2020 legislation (and other relevant programmes) with individual MEPs and committees in Parliament to promote diabetes research. When the programmes are running EURADIA aims to be in contact with European Commission staff and committees to ensure that diabetes research retains a high profile. EURADIA provides Parliament and Commission with information about diabetes research.

 

EURADIA works independently and together with other organisations including the European Coalition for Diabetes (ECD), which have a wider scope beyond diabetes research. Diabetes research can be highlighted at specific events in the European Parliament and Commission calendars such as the Parliament elections in 2014 and the rotational Presidencies of the Council of the European Union.  In discussions on diabetes research it is important to highlight the European Parliament Resolution for the EU Diabetes Epidemic.

 

Information on Horizon 2020 can be found on:  http://ec.europa.eu/research/horizon2020/index_en.cfm

 

Overall objective

·  Ensure that diabetes research is well placed for future calls under Horizon 2020, the new EU Framework Programme for Research and Innovation 2014-2020

 

Specific objectives

·  Design and implement an EU advocacy campaign targeting all three EU institutions (European Commission, European Parliament and Council of the European Union) to position and continue raising the profile of diabetes research at EU policy level

·  Ensure the proper inclusion of diabetes research in the new Horizon 2020 proposals so as to secure earmarked funding

 

Background to health research in Horizon 2020

·  On 30 November 2011 the Commission published a package of proposals for Horizon 2020, a new €80 billion EU Framework Programme for Research and Innovation for 2014-2020

 

·  Horizon 2020 is structured around three pillars:

o   Excellent Science

o   Industrial Leadership

o   Societal Challenges

 

·  Health is addressed under Horizon 2020’s third pillar on Societal Challenges which allocates €9,077 billion to tackle “Health, demographic change and wellbeing”

 

·  Diabetes is mentioned as one of the chronic conditions, which are major causes of disability, ill health and premature death, and present considerable social and economic costs. In the current economic context and given the rising cost of health and social care, the Commission highlights the need for an appropriate European level response to research and innovation in the area of chronic diseases

 

·  The focus of EURADIA’s advocacy campaign was on Horizon 2020’s third pillar to showcase diabetes as a societal challenge that can be addressed through increased research, hence the need for increased research funding




DG Research - 7th Framework Programme (2007-2013)
The Seventh Framework Programme (FP7) bundles all research-related EU initiatives together under a common roof playing a crucial role in reaching the goals of growth, competitiveness and employment; along with a new Competitiveness and Innovation Framework Programme (CIP), Education and Training programmes, and Structural and Cohesion Funds for regional convergence and competitiveness. It is also a key pillar for the European Research Area (ERA).

The broad objectives of FP7 have been grouped into four categories: Cooperation, Ideas, People and Capacities. For each type of objective, there is a specific programme corresponding to the main areas of EU research policy. All specific programmes work together to promote and encourage the creation of European poles of (scientific) excellence.

The non-nuclear research activities of the Joint Research Centre (JRC) are grouped under a specific programme with individual budget allocation.

Further information on each of these specific programmes and their sub-divisions:
http://cordis.europa.eu/fp7/info-programmes_en.html
Further information about the Health Programme:

http://cordis.europa.eu/fp7/health/home_en.html

 




DG Research - 6th Framework Programme (2002-2006)

Newcomers to EU-funded R&D programmes as well as experienced project participants will find FP6 information on this website. This portal provides a single entry point to the family of CORDIS FP6 web services and tools.
The CORDIS FP6 service is built around a suite of interactive and user-friendly support modules to provide you with a comprehensive set of information and tools to support participation in FP6.
http://cordis.europa.eu/fp6/sitemap.htm

Find an FP6 project: http://cordis.europa.eu/fp6/projects.htm

Recent News

22/05/13

"A global collaboration to stop the epidemic" urges Máire Geoghegan-Quinn, European Commissioner for Research, Innovation and Science, in an article in Horizon Magazine.

Read more
16/05/13

Read a welcome from new chairman Michael Stumvoll.

Read more
02/10/12

EURADIA is at the EASD, visit our stand in the Associations' Village.  We invite you to take part in the consultation on the EPCRD!

Read more
European Coalition for Diabetes DIAMAP Road Map for Diabetes Research in Europe Newsletter May 2013

Address: Milnwood, 13 North Parade, Horsham, West Sussex, RH12 2BT, UK
Tel/Fax: 0044 (0)1403 276363

Disclaimer Notice Follow EURADIA on Twitter